Dr Anna López Plana studied Pharmacy at the University of Barcelona, doing her PhD at the Retrovirology and Viral Immunopathology Laboratory of the Hospital Clínic de Barcelona. After a brief stay in the Pharmacology Laboratory of the same hospital, she joined the Molecular and Translational Oncology group at Cellex-IDIBAPS, where she has been working for ten years. She currently works as a laboratory technician in the NeoVaCan group at IrsiCaixa.